Announcements Trials
Browse Landscape

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Endocrine 5Sarcoma 2NET 2Breast 2Other 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 1422Pancreatic Neoplasms 847Carcinoma, Hepatocellular 736Stomach Neoplasms 639Colonic Neoplasms 441Rectal Neoplasms 400Esophageal Neoplasms 395Carcinoma, Non-Small-Cell Lung 328Breast Neoplasms 328Neoplasms 300Liver Neoplasms 280Cholangiocarcinoma 242Ovarian Neoplasms 240Lung Neoplasms 238Neoplasm Metastasis 237Gastrointestinal Neoplasms 216Melanoma 184Prostatic Neoplasms 162Esophageal Squamous Cell Carcinoma 160Biliary Tract Neoplasms 160Endometrial Neoplasms 141Squamous Cell Carcinoma of Head and Neck 128Uterine Cervical Neoplasms 127Carcinoma, Renal Cell 113Head and Neck Neoplasms 112Sarcoma 100Urinary Bladder Neoplasms 95Adenocarcinoma Of Esophagus 89Triple Negative Breast Neoplasms 84Anus Neoplasms 83

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hyperinsulinism × Gastrointestinal × 1 year × Clear all
NCT06041906 2025-06-18

IRCPSS

University Hospital, Geneva

Enrolling by invitation
500 enrolled
Gastrointestinal

Congenital Portosystemic Shunt, Hepatic Encephalopathy, Hyperinsulinism, Hypertension, Pulmonary, Hypoglycemia, Insulin Resistance, Liver Neoplasms, Hyperandrogenism, Hepatopulmonary Syndrome, Hyperammonemia, Rare Diseases, Vascular Malformations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡